Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grisham

Showing results (781-790 of 834) with videos related to

Pageof 84
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 11, 2022
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservationBeryl Manning-Geist, Sushmita Gordhandas, Anjelica Hodgson, et al.
Gynecologic Oncology Reports|April 9, 2026
Characterizing therapeutic target antigen expression in anaplastic carcinoma of the ovaryMackenzie W Sullivan, M Herman Chui, Alexa N Kanbergs, et al.
Cancers|November 20, 2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaHarini Veeraraghavan, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013A Oseledchyk, M M Leitao, J Konner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Optics Letters|September 1, 2005
Nanoimaging with a compact extreme-ultraviolet laserG Vaschenko, F Brizuela, C Brewer, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
Frontiers in Immunology|August 22, 2022
Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertensionValerie J Rodriguez-Irizarry, Alina C Schneider, Daniel Ahle, et al.
Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Pageof 84

Showing results (781-790 of 834) with videos related to

Sort By:
Pageof 84
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 11, 2022
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservationBeryl Manning-Geist, Sushmita Gordhandas, Anjelica Hodgson, et al.
Gynecologic Oncology Reports|April 9, 2026
Characterizing therapeutic target antigen expression in anaplastic carcinoma of the ovaryMackenzie W Sullivan, M Herman Chui, Alexa N Kanbergs, et al.
Cancers|November 20, 2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaHarini Veeraraghavan, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013A Oseledchyk, M M Leitao, J Konner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Optics Letters|September 1, 2005
Nanoimaging with a compact extreme-ultraviolet laserG Vaschenko, F Brizuela, C Brewer, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
Frontiers in Immunology|August 22, 2022
Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertensionValerie J Rodriguez-Irizarry, Alina C Schneider, Daniel Ahle, et al.
Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Pageof 84